Article Details
Retrieved on: 2024-06-26 17:09:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche (OTC:RHHBY) announced that the European Commission has granted marketing authorization to the subcutaneous formulation of relapsing mul...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here